Fluorescent microangiography is a novel and widely applicable technique for delineating the renal microvasculature

PLoS ONE

Volumn 6, Issue 10, 2011, Pages

  Advani, Andrew ^a   Connelly, Kim A ^a   Yuen, Darren A ^a   Zhang, Yanling ^a   Advani, Suzanne L ^a   Trogadis, Judy ^a   Kabir, M Golam ^a   Shachar, Etai ^a   Kuliszewski, Michael A ^a   Leong Poi, Howard ^a   Stewart, Duncan J ^b   Gilbert, Richard E ^a  

^a ST MICHAEL'S HOSPITAL   (Canada)

^b OTTAWA HOSPITAL RESEARCH INSTITUTE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AGAROSE; POLYSTYRENE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CAPILLARY DENSITY; CONFOCAL MICROSCOPY; CONTROLLED STUDY; FLUORESCENCE ANGIOGRAPHY; IMAGE ANALYSIS; IMMUNOHISTOCHEMISTRY; INTERMETHOD COMPARISON; KIDNEY BLOOD FLOW; KIDNEY BLOOD VESSEL; KIDNEY CIRCULATION; KIDNEY PERFUSION; MALE; MICROANGIOGRAPHY; MICROVASCULATURE; NEPHRECTOMY; NONHUMAN; RAT; SHAM PROCEDURE; THREE DIMENSIONAL IMAGING; TISSUE SECTION; ANIMAL; KIDNEY; METHODOLOGY; PATHOLOGY; RADIOGRAPHY; SPRAGUE DAWLEY RAT; VASCULARIZATION;

RATTUS;

ANIMALS; FLUORESCEIN ANGIOGRAPHY; KIDNEY; MALE; MICROVESSELS; NEPHRECTOMY; RATS; RATS, SPRAGUE-DAWLEY;

EID: 80053442677     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0024695     Document Type: Article

References (28)

1. Fine LG, Norman JT, (2008) Chronic hypoxia as a mechanism of progression of chronic kidney diseases: from hypothesis to novel therapeutics. Kidney Int 74: 867-872.
2. Fogo AB, (2005) New capillary growth: a contributor to regression of sclerosis? Curr Opin Nephrol Hypertens 14: 201-203.
3. Remuzzi G, Benigni A, Remuzzi A, (2006) Mechanisms of progression and regression of renal lesions of chronic nephropathies and diabetes. J Clin Invest 116: 288-296.
4. Matsui K, Nagy-Bojarsky K, Laakkonen P, Krieger S, Mechtler K, et al. (2003) Lymphatic microvessels in the rat remnant kidney model of renal fibrosis: aminopeptidase p and podoplanin are discriminatory markers for endothelial cells of blood and lymphatic vessels. J Am Soc Nephrol 14: 1981-1989.
5. Kang DH, Joly AH, Oh SW, Hugo C, Kerjaschki D, et al. (2001) Impaired angiogenesis in the remnant kidney model: I. Potential role of vascular endothelial growth factor and thrombospondin-1. J Am Soc Nephrol 12: 1434-1447.
6. Kang DH, Kanellis J, Hugo C, Truong L, Anderson S, et al. (2002) Role of the microvascular endothelium in progressive renal disease. J Am Soc Nephrol 13: 806-816.
7. Dutly AE, Kugathasan L, Trogadis JE, Keshavjee SH, Stewart DJ, et al. (2006) Fluorescent microangiography (FMA): an improved tool to visualize the pulmonary microvasculature. Lab Invest 86: 409-416.
8. Pillebout E, Burtin M, Yuan HT, Briand P, Woolf AS, et al. (2001) Proliferation and remodeling of the peritubular microcirculation after nephron reduction: association with the progression of renal lesions. Am J Pathol 159: 547-560.
9. Kim YG, Suga SI, Kang DH, Jefferson JA, Mazzali M, et al. (2000) Vascular endothelial growth factor accelerates renal recovery in experimental thrombotic microangiopathy. Kidney Int 58: 2390-2399.
10. Lasch J, Moschner S, Sann H, Zellmer S, Koelsch R, (1998) Aminopeptidase P-a cell-surface antigen of endothelial and lymphoid cells: catalytic and immuno-histotopical evidences. Biol Chem 379: 705-709.
11. Oh P, Li Y, Yu J, Durr E, Krasinska KM, et al. (2004) Subtractive proteomic mapping of the endothelial surface in lung and solid tumours for tissue-specific therapy. Nature 429: 629-635.
12. Kosugi T, Nakayama T, Li Q, Chiodo VA, Zhang L, et al. (2010) Soluble Flt-1 gene therapy ameliorates albuminuria but accelerates tubulointerstitial injury in diabetic mice. Am J Physiol Renal Physiol 298: F609-616.
13. Sharman JE, Brown J, Holland DJ, Macdonald G, Kostner K, et al. (2009) Influence of altered blood rheology on ventricular-vascular response to exercise. Hypertension 54: 1092-1098.
14. Nagaoka T, Yoshida A, (2006) Noninvasive evaluation of wall shear stress on retinal microcirculation in humans. Invest Ophthalmol Vis Sci 47: 1113-1119.
15. Mondy WL, Cameron D, Timmermans JP, De Clerck N, Sasov A, et al. (2009) Micro-CT of corrosion casts for use in the computer-aided design of microvasculature. Tissue Eng Part C Methods 15: 729-738.
16. Terayama H, Ishikawa M, Yasunaga Y, Yamasaki T, Hamaki T, et al. (2011) Prevention of osteonecrosis by intravenous administration of human peripheral blood-derived CD34-positive cells in a rat osteonecrosis model. J Tissue Eng Regen Med 5: 32-40.
17. Miller PL, Scholey JW, Rennke HG, Meyer TW, (1990) Glomerular hypertrophy aggravates epithelial cell injury in nephrotic rats. J Clin Invest 85: 1119-1126.
18. Haylor J, Chowdry J, Baillie H, Cope G, el Nahas AM, (1996) Renal function and morphometry in the dwarf rat following a reduction in renal mass. Nephrol Dial Transplant 11: 643-650.
19. Prior HM, Webster N, Quinn K, Beech DJ, Yates MS, (1998) K(+)-induced dilation of a small renal artery: no role for inward rectifier K+ channels. Cardiovasc Res 37: 780-790.
20. Staudt T, Lang MC, Medda R, Engelhardt J, Hell SW, (2007) 2,2′-thiodiethanol: a new water soluble mounting medium for high resolution optical microscopy. Microsc Res Tech 70: 1-9.
21. Bertram JF, (1995) Analyzing renal glomeruli with the new stereology. Int Rev Cytol 161: 111-172.
22. Scruggs BS, Zuo Y, Donnert E, Ma L, Bertram JF, et al. (2011) Increased capillary branching contributes to angiotensin type 1 receptor blocker (ARB)-induced regression of sclerosis. Am J Pathol 178: 1891-1898.
23. Antiga L, Ene-Iordache B, Remuzzi G, Remuzzi A, (2001) Automatic generation of glomerular capillary topological organization. Microvasc Res 62: 346-354.
24. Yuen DA, Connelly KA, Advani A, Liao C, Kuliszewski MA, et al. (2010) Culture-modified bone marrow cells attenuate cardiac and renal injury in a chronic kidney disease rat model via a novel antifibrotic mechanism. PLoS One 5: e9543.
25. Gilbert RE, Huang Q, Thai K, Advani SL, Lee K, et al. (2011) Histone deacetylase inhibition attenuates diabetes-associated kidney growth: potential role for epigenetic modification of the epidermal growth factor receptor. Kidney Int 79: 1312-1321.
26. Advani A, Kelly DJ, Advani SL, Cox AJ, Thai K, et al. (2007) Role of VEGF in maintaining renal structure and function under normotensive and hypertensive conditions. Proc Natl Acad Sci U S A 104: 14448-14453.
27. Advani A, Kelly DJ, Cox AJ, White KE, Advani SL, et al. (2009) The (Pro)renin receptor: site-specific and functional linkage to the vacuolar H+-ATPase in the kidney. Hypertension 54: 261-269.
28. Advani A, Gilbert RE, Thai K, Gow RM, Langham RG, et al. (2009) Expression, localization, and function of the thioredoxin system in diabetic nephropathy. J Am Soc Nephrol 20: 730-741.